Intestine and Lower Gastrointestinal Tract ·
Out of 765 patients with T1 and T2 colorectal cancer, 11.3% had lymph node metastasis (LNM), leading to a poorer recurrence-free survival (RFS) compared to patients without LNM (72.6% vs. 88.6%). Multivariable analysis revealed that high-grade tumors were a significant risk factor for LNM. Radical surgery should be considered for T1 and T2 colorectal cancer patients with high-grade tumors to improve their prognosis.
Journal Article by Kim EM, Son IT (…) Kim JW et 3 al. in J Clin Med
Summaries are written to help you decide what to read. They do not replace the full paper.
Free · 5 minutes a day
Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.
More in Intestine and Lower Gastrointestinal Tract
A Japanese randomized trial found that a 14-day schedule of trifluridine-tipiracil plus bevacizumab keeps patients with metastatic colorectal cancer alive as long as the standard 28-day schedule, with far less toxicity.
Five years after surgery for low rectal cancer, patients operated on robotically did as well as those operated on laparoscopically, according to a randomized trial from three Korean centres.
Patients smoking at diagnosis were less likely to have a favorable response to treatment before rectal cancer surgery; former smokers were not.
